Broad Public Support For Legalizing Medical Marijuana

Report Read time:
Broad Public Support For Legalizing Medical Marijuana

With a growing number of states moving to legalize medical marijuana, nearly three-quarters of Americans (73%) say they favor their state allowing the sale and use of marijuana for medical purposes if it is prescribed by a doctor, while 23% are opposed. Support for legalizing medical marijuana spans all major political and demographic groups, and is equally high in states that have and have not already passed laws on this issue.

There are public concerns about legalizing medical marijuana. For example, 45% say they would be very or somewhat concerned if a store that sold medical marijuana opened near other stores in their area. And roughly the same percentage (46%) says allowing medical marijuana makes it easier for people to get marijuana even if they don't have a real medical need – though just 26% of Americans say this is something that concerns them. These concerns are highest among opponents of legalizing medical marijuana, but are no higher or lower in states that already allow marijuana for medical purposes.

Far more Americans favor allowing marijuana for prescribed medical purposes than support a general legalization of marijuana. But the proportion supporting legalizing marijuana use has continued to rise over the past two decades.

The most recent national survey by the Pew Research Center for the People & the Press, conducted March 10-14 among 1,500 adults on landlines and cell phones, finds that 41% of the public thinks the use of marijuana should be made legal while 52% do not. In 2008, 35% said it should be legal and 57% said the use of marijuana should not be legal, according to data from the General Social Survey. Twenty years ago, only 16% of the public said the use of marijuana should be legal and 81% said it should not be legal.

Read the full report Broad Public Support For Legalizing Medical Marijuana on the Pew Research Center's Web site.

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up

MORE FROM PEW

A worker in a seafood market dumps bright orange shrimp from a blue bin onto a bed of ice between a lot of other seafood laid out for sale. Other workers are visible in the background, as are the arms of shoppers placing orders from the other side of the ice bed. Seafood Industry Benefits From Greater Vessel Transparency
An aerial view of a vast wetland, with scattered vegetation visible on sandy islands. In Western Australia, a Conservation Model for the World
A presentation being given by a businesswoman to a group of participants at a business conference. Four Plan Features Can Boost 'Retirement Readiness'
A large group of people in formal or traditional attire stands together on a stage, with a digital background depicting marine life and the large text “WTO Agreement on Fisheries Subsidies.” WTO Needs to Redouble Its Effort on Fishing Subsidies
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics
Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.
Quick View
Pills illustration

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.